Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-21
DOI
https://doi.org/10.3389/fphar.2025.1690739
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis

Dandan Yang, Hao Yan, Hutao Yan, Jingwen Zhang
Frontiers in Pharmacology
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis

Dandan Yang, Hao Yan, Hutao Yan, Jingwen Zhang
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Henan University of Traditional Chinese Medicine (CN), Riverside Hospital of Guangxi Zhuang Autonomous Region (CN), Weifang Chinese Medicine Hospital (CN)
Openalex Percentile: Top 83%
Chronic Obstructive Pulmonary Disease (COPD) Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.